{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T09:16:42Z","timestamp":1794734202118,"version":"4.9.1"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Previous research has established an association between vitamin D deficiency and various non-skeletal metabolic disorders. However, the potential association between vitamin D status and specific clinical manifestations including renal dysfunction, primary aldosteronism (PA), and cardiovascular function-related indicators in patients with hypertension remains poorly elucidated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 250 consecutive patients with hypertension who were hospitalized in the Senior Cardiology Department of the Sixth Medical Center of the Chinese PLA General Hospital were enrolled in this study. Volunteers currently supplementing with vitamin D have been excluded. Fasting peripheral venous blood samples were collected from all participants for routine biochemical assays. All participants underwent a comprehensive set of examinations, including transthoracic echocardiography, ambulatory blood pressure monitoring, and routine urinalysis. Serum levels of 25-hydroxyvitamin D (25-OH-D) were measured to evaluate vitamin D status. Relevant clinical and physiological indicators were recorded. Differences in auxiliary examination results and physiological indicators between subgroups were compared and analyzed. The correlations of serum 25-OH-D levels with renal function parameters, cardiovascular function-related indicators, and PA status were further investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of all participants, 165 patients had vitamin D deficiency (serum 25-OH-D\u202f&amp;lt;\u202f50\u202fnmol\/L), whereas 85 patients had non-deficient vitamin D status (serum 25-OH-D\u202f\u2265\u202f50\u202fnmol\/L). There were no statistically significant differences in age, gender, and body mass index (BMI) between the two groups. Compared with the non-deficient group, patients in the vitamin D deficiency group (25-OH-D\u202f&amp;lt;\u202f50\u202fnmol\/L) had significantly lower levels of hematocrit, red blood cell count, hemoglobin, serum calcium, urinary uric acid, and urinary creatinine, as well as significantly higher levels of serum sodium, supine aldosterone concentration, supine aldosterone-to-renin ratio (ARR), and upright aldosterone concentration (all\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.05). Binary logistic regression analysis revealed that PA was significantly associated with vitamin D deficiency (\n                      <jats:italic>OR<\/jats:italic>\n                      0.210, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      0.045\u20130.974,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.046). Multivariate linear regression analysis demonstrated that serum 25-OH-D levels were independently and inversely associated with estimated glomerular filtration rate (eGFR) (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u202f=\u202f\u22124.348,\n                      <jats:italic>t<\/jats:italic>\n                      \u202f=\u202f\u22123.082,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.002). Patients with chronic kidney disease (CKD) had a significantly larger left atrial anteroposterior diameter [39(36,42) vs. 36(32,39) mm,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.001] and pulmonary artery diameter [24(22,26) vs. 23(21,25) mm,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.010], along with a higher 24-h mean systolic blood pressure (131\u202f\u00b1\u202f11 vs. 127\u202f\u00b1\u202f11\u202fmmHg,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.042), but a lower 24-h mean diastolic blood pressure (73\u202f\u00b1\u202f10 vs. 77\u202f\u00b1\u202f9\u202fmmHg,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.042), compared with those without renal dysfunction.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>After adjustment for traditional cardiovascular risk factors, PA remained independently associated with vitamin D deficiency in patients with hypertension. Vitamin D and retinol-binding protein were significantly associated with renal dysfunction in this patient population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1741253","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:53:03Z","timestamp":1780462383000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between vitamin D deficiency and adrenal gland, kidney function, indicators related to cardiovascular function in hypertensive patients"],"prefix":"10.3389","volume":"13","author":[{"given":"Minglei","family":"Zhang","sequence":"first","affiliation":[{"name":"Senior Department of Cardiology, The Sixth Medical Center of Chinese PLA General Hospital","place":["Beijing, China"]},{"name":"School of Medicine, Nankai University","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunyuan","family":"Wang","sequence":"additional","affiliation":[{"name":"The Fifth Clinical College, Anhui Medical University","place":["Hefei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiping","family":"Pan","sequence":"additional","affiliation":[{"name":"The Fifth Clinical College, Anhui Medical University","place":["Hefei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizhe","family":"Li","sequence":"additional","affiliation":[{"name":"Chinese PLA Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Medicine, Nankai University","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Jin","sequence":"additional","affiliation":[{"name":"School of Medicine, Nankai University","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongbin","family":"Li","sequence":"additional","affiliation":[{"name":"Senior Department of Cardiology, The Sixth Medical Center of Chinese PLA General Hospital","place":["Beijing, China"]},{"name":"School of Medicine, Nankai University","place":["Tianjin, China"]},{"name":"The Fifth Clinical College, Anhui Medical University","place":["Hefei, China"]},{"name":"Chinese PLA Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1016\/j.clnu.2020.12.025","article-title":"Vitamin D and cardiovascular health","volume":"40","author":"de la Gu\u00eda-Galipienso","year":"2021","journal-title":"Clin Nutr"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1161\/CIRCULATIONAHA.113.002654","article-title":"Role of vitamin D in atherosclerosis","volume":"128","author":"Kassi","year":"2013","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.jcot.2019.07.004","article-title":"Vitamin D for skeletal and non-skeletal health: what we should know","volume":"10","author":"Charoenngam","year":"2019","journal-title":"J Clin Orthop Trauma"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"6483","DOI":"10.3390\/ijms21186483","article-title":"Vitamin D and cardiovascular disease, with emphasis on hypertension, atherosclerosis, and heart failure","volume":"21","author":"Latic","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.autrev.2010.06.009","article-title":"Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice","volume":"9","author":"Souberbielle","year":"2010","journal-title":"Autoimmun Rev"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1027841","DOI":"10.3389\/fendo.2022.1027841","article-title":"Bone and mineral metabolism in patients with primary aldosteronism: a systematic review and meta-analysis","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/cen.14177","article-title":"The effect of vitamin D treatment on clinical and biochemical outcomes of primary aldosteronism","volume":"92","author":"Ismail","year":"2020","journal-title":"Clin Endocrinol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.bbalip.2010.04.009","article-title":"1alpha,25-Dihydroxyvitamin D3 affects hormone production and expression of steroidogenic enzymes in human adrenocortical NCI-H295R cells","volume":"1801","author":"Lundqvist","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jsbmb.2017.01.021","article-title":"Vitamin D supplementation guidelines","volume":"175","author":"Pludowski","year":"2018","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"E1283","DOI":"10.1210\/jc.2013-1195","article-title":"Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine","volume":"98","author":"Bouillon","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3390\/ijms19020455","article-title":"The impact of vitamin D in the treatment of essential hypertension","volume":"19","author":"Legarth","year":"2018","journal-title":"Int J Mol Sci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.2174\/138161209789058093","article-title":"Oxidative stress, endothelial dysfunction and atherosclerosis","volume":"15","author":"Victor","year":"2009","journal-title":"Curr Pharm Des"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ijcard.2015.02.012","article-title":"Vitamin D deficiency and atrial fibrillation","volume":"184","author":"Thompson","year":"2015","journal-title":"Int J Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/eurjhf\/hfr175","article-title":"Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome","volume":"14","author":"Gotsman","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.pcad.2009.12.003","article-title":"Aldosterone and mineralocorticoid receptors in the cardiovascular system","volume":"52","author":"Funder","year":"2010","journal-title":"Prog Cardiovasc Dis"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.tem.2013.05.003","article-title":"Primary aldosteronism: emerging trends","volume":"24","author":"Galati","year":"2013","journal-title":"Trends Endocrinol Metab"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1555572","DOI":"10.3389\/fendo.2025.1555572","article-title":"Screening for primary aldosteronism in 1,181 Swedish primary care patients with hypertension","volume":"16","author":"Makhnov","year":"2025","journal-title":"Front Endocrinol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"638S","DOI":"10.1093\/ajcn\/61.3.638S","article-title":"Environmental factors that influence the cutaneous production of vitamin D","volume":"61","author":"Holick","year":"1995","journal-title":"Am J Clin Nutr"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"929.e1","DOI":"10.1016\/j.jaad.2009.07.028","article-title":"Estimated equivalency of vitamin D production from natural sun exposure versus oral vitamin D supplementation across seasons at two US latitudes","volume":"62","author":"Terushkin","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/jcb.10343","article-title":"Vitamin D regulation of the renin-angiotensin system","volume":"88","author":"Li","year":"2003","journal-title":"J Cell Biochem"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"145828","DOI":"10.1155\/2015\/145828","article-title":"Interplay of vitamin D, erythropoiesis, and the renin-angiotensin system","volume":"2015","author":"Santoro","year":"2015","journal-title":"Biomed Res Int"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1530\/EJE-17-0417","article-title":"Primary aldosteronism as a cause of secondary osteoporosis","volume":"177","author":"Salcuni","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"574151","DOI":"10.3389\/fendo.2020.574151","article-title":"Primary Aldosteronism and bone metabolism: a systematic review and Meta-analysis","volume":"11","author":"Shi","year":"2020","journal-title":"Front Endocrinol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.cardiores.2006.03.007","article-title":"Oxidative stress in aldosteronism","volume":"71","author":"Sun","year":"2006","journal-title":"Cardiovasc Res"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/MED.0000000000000062","article-title":"Interactions between adrenal-regulatory and calcium-regulatory hormones in human health","volume":"21","author":"Brown","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"752","DOI":"10.4065\/mcp.2010.0138","article-title":"Vitamin D deficiency in adults: when to test and how to treat","volume":"85","author":"Kennel","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/s1357-2725(01)00165-0","article-title":"Basal and parathyroid hormone induced expression of the human 25-hydroxyvitamin D 1alpha-hydroxylase gene promoter in kidney AOK-B50 cells: role of Sp1, Ets and CCAAT box protein binding sites","volume":"34","author":"Gao","year":"2002","journal-title":"Int J Biochem Cell Biol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.bonr.2018.02.004","article-title":"Physiologic and pathophysiologic roles of extra renal CYP27b1: case report and review","volume":"8","author":"Bikle","year":"2018","journal-title":"Bone Rep"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/jch.12825","article-title":"Effects of vitamin D supplementation on plasma aldosterone and renin-a randomized placebo-controlled trial","volume":"18","author":"Gr\u00fcbler","year":"2016","journal-title":"J Clin Hypertens"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1172\/JCI15219","article-title":"1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system","volume":"110","author":"Li","year":"2002","journal-title":"J Clin Invest"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1210\/jcem-59-6-1063","article-title":"Plasma vitamin D metabolite concentrations in chronic renal failure: effect of oral administration of 25-hydroxyvitamin D3","volume":"59","author":"Halloran","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s13277-015-3230-8","article-title":"Molecular mechanism underlying the tumor-promoting functions of carcinoma-associated fibroblasts","volume":"36","author":"Han","year":"2015","journal-title":"Tumour Biol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic kidney disease diagnosis and management: a review","volume":"322","author":"Chen","year":"2019","journal-title":"JAMA"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.amjcard.2006.01.059","article-title":"Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease","volume":"98","author":"Ferrario","year":"2006","journal-title":"Am J Cardiol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"10A","DOI":"10.1016\/j.amjcard.2009.10.006","article-title":"Progression of cardiovascular damage: the role of renin-angiotensin system blockade","volume":"105","author":"Probstfield","year":"2010","journal-title":"Am J Cardiol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11906-012-0248-9","article-title":"Vitamin D and vascular disease: the current and future status of vitamin D therapy in hypertension and kidney disease","volume":"14","author":"Vaidya","year":"2012","journal-title":"Curr Hypertens Rep"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1741253\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:53:06Z","timestamp":1780462386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1741253\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":39,"alternative-id":["10.3389\/fnut.2026.1741253"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1741253","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"article-number":"1741253"}}